Genomics in Clinical trials for Breast Cancer.

🤖 Plain-English Summary

Breast cancer (B.C.) still has increasing incidences and mortality rates globally. Genomics studies assist with patient outcomes improvement and oncology advancement by providing a deeper understanding of the biology behind breast cancer.

🔑 Key Findings

• and other cancers have a very high rate of genetic heterogeneity and genomic mutations.
• Traditional oncology approaches have not been able to provide a lasting solution.
• Targeted therapeutics have been instrumental in handling the complexity and resistance associated with B.C.

🔗 Related Resources